Hyrax Biosciences

Hyrax Biosciences is a South African genomics software company that develops cloud-based DNA sequence analysis tools for clinical and public health laboratories. Its Exatype platform automates next-generation sequencing (NGS) data analysis for infectious diseases including HIV drug-resistance testing, TB drug-susceptibility testing, and SARS-CoV-2 genotyping, reducing complex sequencing workflows to actionable clinical reports. Hyrax serves diagnostic labs and public health programs globally and co-markets integrated workflows with Roche for sample preparation through to reporting, enabling affordable and scalable genetic diagnostics in resource-limited settings.